Skip to main content

Zaponex (clozapine) Orodispersible Tablets

Leyden Delta is the first UK clozapine supplier to introduce an orodispersible clozapine formulation.

Zaponex ODTs will complement our existing portfolio by providing a complete range of dosage strengths designed to help you to individualise and simplify your patients’ titration and maintenance regimens, improve accuracy of dosing when compared to liquid formulations and reduce tablet burden.

Strengths Available

200mg

100mg

50mg

25mg

12.5mg

Suitable for Vegan and Lactose-Intolerant Patients

Support Materials

Patient Leaflets

Pharmacy Brochure

Our Pharmacy Brochure provides technical data about Zaponex® ODT. It is available in both hard copy or digital format.

Titration Charts

Request Zaponex Information Pack

Summary of Product Characteristics

Patient Information Leaflet

Zaponex ODT Abbreviated Prescribing Information

Make an Enquiry

News & Updates

Zaponex ODT Tablet Updates
November 24, 2020

Zaponex Orodispersible Tablet Price Reduction

Dear  Healthcare colleague,  Leyden Delta brought to market the first and only orodispersible clozapine tablet in the UK and has recently reviewed the prices of Zaponex (clozapine) Orodispersible tablets. As a result,  the new list prices* are as follows: *List…
Zaponex-admin
Love0
Zaponex ODT Tablet Updates
July 29, 2020

Update to Zaponex Orodispersible Tablet Product Information

Please be informed of a recent update to the product information for Zaponex 12.5 mg, 25 mg, 50 mg, 100 mg and 200 mg orodispersible tablets. Zaponex ODT Summary of Product Characteristics (SPC): Section 6.3: Extension of the shelf life…
Zaponex-admin
Love0

Report Side Effects

Yellow Card Scheme

Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme.
Yellow Card Scheme

ZTAS

Adverse events should also be reported to ZTAS.
T: (0207)365 58 42  |  F: (0207)365 58 43  |  E: info@ztas.co.uk
ZTAS